Department of Neuroradiology, Institute of Clinical Radiology.
Department of Neurosurgery, and.
J Neurosurg. 2017 Feb;126(2):360-367. doi: 10.3171/2016.2.JNS152081. Epub 2016 Apr 29.
OBJECTIVE Sinus-preserving (SP) embolization techniques augment endovascular treatment options for intracranial lateral dural arteriovenous fistulas (DAVFs). The authors aimed to perform a retrospective comparison of their primary success rates, complication rates, and long-term follow-up with those of sinus-occluding (SO) treatment variants in the collective of low- and intermediate-grade lateral DAVFs (Cognard Types I-IIb). METHODS Clinical symptoms, complication rates, and Cognard grading prior to and after endovascular DAVF treatment using different technical approaches was retrospectively analyzed in 36 patients with lateral DAVF Cognard Types I-IIb. The long-term success rate was determined by a standardized questionnaire. RESULTS The SO approaches offered a higher rate of definitive fistula occlusion (93% SO vs 71% SP) but were accompanied by a significantly higher complication rate (33% or 20% SO vs 0% SP). The patients interviewed reported very high satisfaction with their health in long-term follow-up in both groups. CONCLUSIONS A higher rate of definitive fistula occlusion in the SO group was attained at the price of a significantly higher complication rate. The SP approaches offered a good primary success rate in combination with a very low complication rate. Despite some limitations of the data (e.g., a small sample size) the authors thus recommend an SP variant as the primary therapeutic option for the endovascular treatment of low- and intermediate-grade DAVFs. The SO approaches should be restricted to cases in which SP treatment does not achieve a downgrading to no worse than Cognard Type IIa.
保留窦腔(SP)栓塞技术增加了颅内外侧硬脑膜动静脉瘘(DAVF)的血管内治疗选择。作者旨在对低级别和中级别外侧 DAVF(Cognard Ⅰ-Ⅱb 型)患者中,SP 治疗和 SO 治疗变体的初次成功率、并发症发生率和长期随访结果进行回顾性比较。
回顾性分析了 36 例外侧 DAVF Cognard Ⅰ-Ⅱb 型患者采用不同技术方法进行血管内 DAVF 治疗前后的临床症状、并发症发生率和 Cognard 分级。采用标准化问卷确定长期成功率。
SO 方法提供了更高的确定性瘘管闭塞率(93% SO 与 71% SP),但并发症发生率明显更高(33% 或 20% SO 与 0% SP)。接受采访的患者在长期随访中均报告健康状况非常满意。
SO 组通过更高的确定性瘘管闭塞率实现了更高的并发症发生率。SP 方法在结合非常低的并发症发生率的情况下提供了良好的初次成功率。尽管数据存在一些局限性(例如,样本量小),作者仍然建议 SP 变体作为低级别和中级别 DAVF 血管内治疗的首选治疗方案。SO 方法应限于 SP 治疗不能降级至 Cognard Ⅱa 型以下的情况。